[
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
[og_img]
https://www.investing.com/news/press-releases/reviva-to-present-brilaroxazine-topline-data-for-longterm-ole-portion-of-recover-study-in-schizophrenia-at-2025-sirs-congress-93CH-3956216
Investing.com
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
Related articles